FMC CORP

FMC's capital structure shows a debt-to-equity ratio of 1.84, indicating a significant reliance on debt financing. The company's liquidity position is moderate, with a current ratio of 1.29 and cash and equivalents of $390.9 million, which is less than the combined short and long-term debt of $3.36 billion. The negative net income of $281.3 million and operating loss of $81 million in Q1 2026 suggest financial stress, with return on equity at -15.44% and return on assets at -2.99%. Profitability metrics for FMC are below the industry median for Agricultural Chemicals. The company's gross margin of 32.5% (calculated from $246.6 million gross profit on $758.6 million revenue) is lower than the industry median of 38.2%. Operating margin is negative at -10.7%, compared to a median of 12.4% in the sector. The company's return on equity of -15.44% is significantly below the industry median of 14.2%. Geographically, FMC's revenue is concentrated in North America and Europe, with emerging markets contributing a smaller share. The company's exposure to the Indian market is notable, with a business unit classified as held for sale with a carrying value of $425 million. This concentration increases vulnerability to regional economic and regulatory shifts. FMC's growth trajectory is mixed. Revenue in Q1 2026 was $758.6 million, a decline from the prior year's $812.4 million. The company's outlook for FY 2026 is for a 6.7% revenue decline, with a projected 12.3% decline in FY 2027. These projections are driven by reduced demand in key markets and ongoing cost pressures. Risk factors for FMC include liquidity constraints, with net cash negative after subtracting total debt, and an inability to assess dilution risk due to missing share count data. The company's exposure to climate change and regulatory shifts in agricultural practices adds to its operational risk. The recent adoption of ASU 2024-03 may also impact financial reporting transparency. Recent events include the classification of the Indian business as held for sale, with assets held for sale totaling $492.9 million and liabilities held for sale of $47.5 million. The company has also initiated an accelerated share repurchase agreement, signaling management's confidence in the stock's value.